Dr. Jamieson on Treatment Considerations in Myelofibrosis
Catriona Jamieson, MD, PhD, discusses treatment considerations for patients with myelofibrosis.
Dr. Jamieson on the Importance of Treating at Diagnosis in Myelofibrosis
Catriona Jamieson, MD, PhD, discusses the importance of treating patients with myelofibrosis at diagnosis.
Dr. Jamieson on Symptom Management in Myelofibrosis
Catriona Jamieson, MD, PhD, discusses symptom management in patients with myelofibrosis.
Rapid Readouts: Phase 2 Study of Navitoclax in High-Risk Myelofibrosis
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
2 Clarke Drive Cranbury, NJ 08512